Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells

  • Badia, Roger|||0000-0003-3982-7577
  • Pujantell, Maria|||0000-0002-9471-5853
  • Riveira Muñoz, Eva|||0000-0002-6396-1162
  • Puig Reixach, Maria Teresa|||0000-0003-1402-7653
  • Torres Torronteras, Javier
  • Martí, Ramon A.|||0000-0002-8273-9540
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Ampudia Carrasco, Rosa María|||0000-0002-0734-0433
  • Vives Pi, Marta|||0000-0003-3735-0779
  • Este, José|||0000-0002-1436-5823
  • Ballana, Ester|||0000-0002-5215-7363
Macrophages are a heterogeneous cell population strongly influenced by differentiation stimuli that become susceptible to HIV-1 infection after inactivation of the restriction factor SAMHD1 by cyclin-dependent kinases (CDK). Here, we have used primary human monocyte-derived macrophages differentiated through different stimuli to evaluate macrophage heterogeneity on cell activation and proliferation and susceptibility to HIV-1 infection. Stimulation of monocytes with GM-CSF induces a non-proliferating macrophage population highly restrictive to HIV-1 infection, characterized by the upregulation of the G1/S-specific cyclin D2, known to control early steps of cell cycle progression. Knockdown of cyclin D2, enhances HIV-1 replication in GM-CSF macrophages through inactivation of SAMHD1 restriction factor by phosphorylation. Co-immunoprecipitation experiments show that cyclin D2 forms a complex with CDK4 and p21, a factor known to restrict HIV-1 replication by affecting the function of the downstream cascade that leads to SAMHD1 deactivation. Thus, we demonstrate that cyclin D2 acts as regulator of cell cycle proteins affecting SAMHD1-mediated HIV-1 restriction in non-proliferating macrophages.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir

  • Badia, Roger|||0000-0003-3982-7577
  • Ballana, Ester|||0000-0002-5215-7363
  • Castellví, Marc
  • García Vidal, Edurne|||0000-0003-0698-8710
  • Pujantell, Maria|||0000-0002-9471-5853
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Prado, Julia G.|||0000-0002-5439-4645
  • Puig, Jordi|||0000-0002-4075-0346
  • Martinez, Miguel Angel|||0000-0002-6681-4950
  • Riveira Muñoz, Eva|||0000-0002-6396-1162
  • Este, José|||0000-0002-1436-5823
CD32 has been shown to be preferentially expressed in latently HIV-1-infected cells in an in vitro model of quiescent CD4 T cells. Here we show that stimulation of CD4+ T cells with IL-2, IL-7, PHA, and anti-CD3/CD28 antibodies induces T-cell proliferation, co-expression of CD32 and the activation of the markers HLA-DR and CD69. HIV-1 infection increases CD32 expression. 79.2% of the CD32+/CD4+ T cells from HIV+ individuals under antiretroviral treatment were HLA-DR+. Resting CD4+ T cells infected in vitro generally results in higher integration of provirus. We observe no difference in provirus integration or replication-competent inducible latent HIV-1 in CD32+ or CD32- CD4+ T cells from HIV+ individuals. Our results demonstrate that CD32 expression is a marker of CD4+ T cell activation in HIV+ individuals and raises questions regarding the immune resting status of CD32+ cells harboring HIV-1 proviruses. CD32 has been previously shown to be expressed preferentially by CD4 T cells latently harbouring HIV-1. Here the authors show that CD32 expression in CD4 T cells is associated with T cell activation, is up-regulated by HIV-1 infection and importantly does not appear to represent an enriched cellular niche for latent HIV-1.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages

  • Pujantell, Maria|||0000-0002-9471-5853
  • Riveira Muñoz, Eva|||0000-0002-6396-1162
  • Badia, Roger|||0000-0003-3982-7577
  • Castellví, Marc
  • García Vidal, Edurne|||0000-0003-0698-8710
  • Sirera, Guillem|||0000-0003-4014-9355
  • Puig Oliva, Teresa
  • Ramirez Soto, Cristina
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Este, José|||0000-0002-1436-5823
  • Ballana, Ester|||0000-0002-5215-7363
ADAR1-dependent A-to-I editing has recently been recognized as a key process for marking dsRNA as self, therefore, preventing innate immune activation and affecting the development and resolution of immune-mediated diseases and infections. Here, we have determined the role of ADAR1 as a regulator of innate immune activation and modifier of viral susceptibility in primary myeloid and lymphoid cells. We show that ADAR1 knockdown significantly enhanced interferon, cytokine and chemokine production in primary macrophages that function as antiviral paracrine factors, rendering them resistant to HIV-1 infection. ADAR1 knockdown induced deregulation of the RLRs-MAVS signaling pathway, by increasing MDA5, RIG-I, IRF7 and phospho-STAT1 expression, an effect that was partially rescued by pharmacological blockade of the pathway. In summary, our results demonstrate a role of ADAR1 in regulating innate immune function in primary macrophages, suggesting that macrophages may play an essential role in disease associated to ADAR1 dysfunction. We also show that viral inhibition is exclusively dependent on innate immune activation consequence of ADAR1 knockdown, pointing towards ADAR1 as a potential target to boost antiviral immune response.